Fred Alger Management, LLC Cytek Biosciences, Inc. Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$8.44 - $13.47 $151 - $242	18 Added 0.02%	106,841 $981,000
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $4,194 - $6,851	432 Added 0.41%	106,823 $1.09 Million
Q2 2022 Aug 15, 2022	SELL	$7.41 - $11.56 $15,731 - $24,541	-2,123 Reduced 1.96%	106,391 $1.14 Million
Q1 2022 May 16, 2022	SELL	$9.89 - $17.25 $5,676 - $9,901	-574 Reduced 0.53%	108,514 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$16.14 - $25.04 $62,816 - $97,455	-3,892 Reduced 3.44%	109,088 $1.78 Million
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $1.98 Million - $3.16 Million	112,980 New	112,980 $2.42 Million

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $874M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.